Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/portal-hypertension-vi/descriptif_3850660
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3850660

Portal Hypertension VI, Softcover reprint of the original 1st ed. 2016 Proceedings of the Sixth Baveno Consensus Workshop: Stratifying Risk and Individualizing Care

Langue : Anglais

Coordonnateur : de Franchis Roberto

Couverture de l’ouvrage Portal Hypertension VI

This book will be an excellent tool for practitioners seeking an update on the latest developments in the diagnosis and management of cirrhosis and portal hypertension. Among the topics addressed are risk stratification, prognosis, screening and surveillance, impact of etiological and antifibrotic therapy, the gut microbiome and cirrhosis, prevention of decompensation/further decompensation, management of the acute bleeding episode, controversies in pediatrics, and vascular diseases of the liver in cirrhotic and noncirrhotic portal hypertension. The book is a compilation of lectures and important consensus statements from the Sixth Baveno International Consensus Workshop on Portal Hypertension, the most recent of a series of workshops held every 5 years for hepatologists with an interest in the field. Portal Hypertension VI will serve as a reference book for clinical and research fellows in Gastroenterology and Hepatology and should inspire new research projects in the areas identified as promising by the experts of the Baveno VI Faculty.

Session 1 - Risk stratification and prognosis.- Session 2 - Screening and surveillance: invasive and noninvasive methods.- Session 3 - Changing scenarios I: Impact of etiological therapy for cirrhosis and of anti-fibrotic therapy on portal hypertension.- Session 4 - The gut microbiome and cirrhosis.- Session 5 - Changing scenarios II: What to do after successful cure of the etiologic factor?.- Session 6 - Management of the acute bleeding episode.- Session 7 - Controversies and challenges in Pediatrics.- Session 8 - Prevention of further decompensation (ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, hepatic encephalopathy).- Session 9 Vascular diseases of the liver in cirrhotic and non-cirrhotic portal hypertension: coagulation, anti-coagulation, anti-platelet drugs.

Roberto de Franchis is Head of the Gastroenterology Unit at the L. Sacco University Hospital, Milan, Italy and Professor of Medicine (Gastroenterology) at the University of Milan. He is a member of several specialist societies and an elected Fellow of the American Gastroenterological Association. Dr. de Franchis has published widely in the fields of Gastroenterology and Hepatology in the major medical and hepatology journals. Every five years since 1990 he has organized the International Consensus Workshop on Definitions, Methodology, and Therapeutic Strategies in Portal Hypertension in Baveno, Italy. In 2010 he was organizer and co-chairman of the European School of Hepatology (EASL) in Barcelona, Spain.

Updates practitioners on the latest developments in the diagnosis and management of cirrhosis and portal hypertension

Offers an ideal reference for clinical and research fellows in Gastroenterology and Hepatology

Will inspire new research projects in areas identified as promising by experts of the Baveno VI Faculty

Date de parution :

Ouvrage de 426 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 158,24 €

Ajouter au panier

Date de parution :

Ouvrage de 426 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 116,04 €

Ajouter au panier